BioPharma Credit (LSE:BPCR) ROE % Adjusted to Book Value : 17.85% (As of Dec. 2022)

View and export this data going back to 2017. Start your Free Trial

What is BioPharma Credit ROE % Adjusted to Book Value?

BioPharma Credit's ROE % for the quarter that ended in Dec. 2022 was 16.78%. BioPharma Credit's PB Ratio for the quarter that ended in Dec. 2022 was 0.94. BioPharma Credit's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2022 was 17.85%.

BioPharma Credit ROE % Adjusted to Book Value Historical Data

The historical data trend for BioPharma Credit's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioPharma Credit ROE % Adjusted to Book Value Chart

BioPharma Credit Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

8.79

6.47

6.39

14.36

9.88

BioPharma Credit Semi-Annual Data
	Jun17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Dec23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial							6.64	6.13	10.67	17.85	-

Competitive Comparison of BioPharma Credit's ROE % Adjusted to Book Value

For the Asset Management subindustry, BioPharma Credit's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioPharma Credit's ROE % Adjusted to Book Value Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, BioPharma Credit's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where BioPharma Credit's ROE % Adjusted to Book Value falls into.

BioPharma Credit ROE % Adjusted to Book Value Calculation

BioPharma Credit's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	8.10%	/	0.82
	=	9.88%

BioPharma Credit's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2022 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	16.78%	/	0.94
	=	17.85%

BioPharma Credit ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of BioPharma Credit's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

BioPharma Credit Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » BioPharma Credit PLC (LSE:BPCR) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

65 Gresham Street, 6th Floor, London, GBR, EC2V 7NQ

Website

https://www.bpcruk.com

BioPharma Credit PLC is an investment company. The investment objective of the company is to generate long-term shareholder returns predominantly in the form of sustainable income distributions from exposure to the life sciences industry. The only reporting segment of the company is the investment in debt assets secured by royalties or other cash flows derived from the sale of approved life sciences products. The company generates revenue in the form of interest income, income from subsidiaries, royalty revenue, make-whole and prepayment income, dividends, and paydown fees. The company earns a majority of its revenue from Investment income.

BioPharma Credit Headlines

No Headlines